Gilead reaches HIV PrEP agreements; Hong Kong investigates Cloudbreak IPO
Plus news about VaxThera, Sironax, Circle Pharma, Nutshell Therapeutics, Evopoint and Sensorion. Gilead’s HIV PrEP pact in Latin America: The California drugmaker said it formed an agreement with the Pan American Health Organization (PAHO) around ...
Gilead has formed an agreement with the Pan American Health Organization (PAHO) regarding HIV PrEP in Latin America, according to Endpoints News.
In Hong Kong, the government aims to increase its expenditure on innovation activities to 3 per cent of gross domestic product (GDP) by around 2030, nearly double the current rate of 1.63 per cent in 2024, as reported by the South China Morning Post.
The South China Morning Post also reported on a Hong Kong developer family's purchase of a luxury flat in Mid-Levels for HK$98.8 million. Meanwhile, stock markets in mainland China and Hong Kong edged higher on Wednesday, led by tech shares, as per Business Recorder.
Brief written by urgent.news from Endpoints News, South China Morning Post, SCMP Business, Business Recorder — 4 reports on this story. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- US crypto bill stumble sparks call for Hong Kong to seize ‘critical strategic window’ scmp.com
- Hong Kong unveils first five-year plan to add jobs, homes, align closer to mainland China investing.com
- China, Hong Kong shares gain on tech strength, as investors await Fed brecorder.com
- Hong Kong crypto exchange CoinEx to shut down after 9 years techinasia.com
